Subscribe
istock-629430458pablo_k-1-
Pablo_K / iStockphoto.com
29 August 2018Big Pharma

Horizon partners with big pharma company on CRISPR

UK-based Horizon Discovery has entered into a CRISPR collaboration with an unnamed big pharma company.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Europe
Horizon Discovery expands CRISPR licence with ERS Genomics
5 December 2017   UK-based genomics company Horizon Discovery has expanded its licence coverage for use of the CRISPR gene-editing technology.
Biotechnology
Horizon Discovery expands CRISPR licence
17 January 2017   UK-based Horizon Discovery has broadened its gene editing capabilities through the amendment of a pre-existing licence with ERS Genomics to include the full commercial rights for the use of CRISPR.


Editor's picks

Life sciences leaders recognised at LSPN Awards USA 2025
Americas
Life sciences leaders recognised at LSPN Awards USA 2025
8 May 2025

Editor's picks

Americas
Life sciences leaders recognised at LSPN Awards USA 2025
8 May 2025

More on this story

Europe
Horizon Discovery expands CRISPR licence with ERS Genomics
5 December 2017   UK-based genomics company Horizon Discovery has expanded its licence coverage for use of the CRISPR gene-editing technology.
Biotechnology
Horizon Discovery expands CRISPR licence
17 January 2017   UK-based Horizon Discovery has broadened its gene editing capabilities through the amendment of a pre-existing licence with ERS Genomics to include the full commercial rights for the use of CRISPR.

More on this story

Europe
Horizon Discovery expands CRISPR licence with ERS Genomics
5 December 2017   UK-based genomics company Horizon Discovery has expanded its licence coverage for use of the CRISPR gene-editing technology.
Biotechnology
Horizon Discovery expands CRISPR licence
17 January 2017   UK-based Horizon Discovery has broadened its gene editing capabilities through the amendment of a pre-existing licence with ERS Genomics to include the full commercial rights for the use of CRISPR.

More features

Life sciences leaders recognised at LSPN Awards USA 2025
UK-India trade deal is ‘a missed opportunity for UK pharma’, says industry body
LSPN: Counsel grapple with AI’s impact on training and critical thinking
'Nothing can stand in the way of our work': Ukraine resumes IP system
LSPN: Trump's policy storm causing chaos and confusion
Taylor Wessing expands in Europe with Paris team
LSPN: Using ‘the patentee’s friend’ in Section 112 claims
ResMed voids sleep apnoea tech patent at PTAB